Investigators are required to be 21 CFR Part 11 compliant. The FDA has stated that citations related to Part 11 would be issued as a result of failures around recordkeeping requirements as delineated in Predicate Rules (e.g., 21 CFR parts 50, 56, 312, and/or 812). While the agency is not presently inspecting directly for it, Part 11 compliance is still very much required.